Find a Trial

Trial Summary


Protocol No.NEUR-AGIOS-AG881-C-004
StatusOPEN TO ACCRUAL
Principal InvestigatorNevel, Kathryn
ScopeNational
PhasePhase III
Age GroupAdults and Children
TitleA Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study of AG-881 in Subjects With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
Applicable Disease SitesBrain and Nervous System
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactLauren Perrey, Phone: +1 317-963-7505
    Pager:
    Email: lperrey@iupui.edu